Circulating Tumour DNA in Clinical Trial Design
Identification of a Predictive Biomarker for an Immune Agonist; Lessons Learned from Vopratelimab
Science to Medicine: Using Biomarkers & Genetics for Indication Selection & Prioritization in Drug Development
